During treatment for HCC, the damage to immune cells arises mainly from: 1) the toxicity of anti-tumor drugs; 2) tumor tissue not being conducive to the survival and function of immune cells; 3) HCC cells affecting immune cells directly through PD-1/PD-L1 (immune escape by inducing T-cell apoptosis). Here, CD274 is linked to hepatocellular carcinoma.